(IN BRIEF) Novonesis, the merger of Novozymes and Chr. Hansen, is now officially completed, solidifying its position as a global leader in biosolutions. With over 10,000 employees worldwide and expertise spanning 30 industries, Novonesis aims to provide biosolutions that benefit … Read the full press release
Posted in Business, Denmark, Management, Pharma & Biotech, Technology
Tagged biosolutions, Cees de Jong, Chr. Hansen, Ester Baiget, Novonesis, Novozymes, statutory merger
(IN BRIEF) Novozymes and Chr. Hansen have unveiled their new collective name, ‘Novonesis,’ symbolizing a fresh beginning in the world of biosolutions. This announcement marks a significant step towards the merger of the two companies. Novonesis, which means ‘A new … Read the full press release
Posted in Business, Denmark, Industrial, Management, News, Pharma & Biotech, Science, Technology
Tagged 'Novonesis', biology, biosolutions, Cees de Jong, Chr. Hansen, Ester Baiget, Novozymes, partnership
Chr. Hansen realized 9% organic growth in Q1 2014/15 and maintains full-year expectations Hørsholm, Denmark, 21-1-2015 — /EuropaWire/ — “With solid organic revenue growth of 9% in Q1 2014/15, Chr. Hansen has started the year well. The Cultures & Enzymes Division (7% … Read the full press release
Posted in Business, Denmark, Financial, Food & Beverage, Management
Tagged Cees de Jong, Chr. Hansen, organic growth in Q1 2014/15
After solid growth in the fourth quarter Chr. Hansen announces strong full-year results that match the expectations for the year Hørsholm, Denmark, 23-10-2014 — /EuropaWire/ — “Chr. Hansen continues to deliver solid growth and strong margins. In 2013/14, organic growth was … Read the full press release
Posted in Business, Denmark, Financial, Food & Beverage, Management
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
